A non-endoscopic device that samples the mucosa for Barrett’s esophagus (BE) is a “promising” alternative to the current standard of endoscopic screening, according to researchers who conducted the first major multicenter trial of the device in the United States.
The study evaluated a recent, but not the latest, version of the Cytosponge (Medtronic). Numerous multicenter trials in Europe have assessed other versions of this device, which is swallowed and is designed to collect